The Global Hydroxychloroquine market is forecasted to reach USD 5.54 Billion by 2027, according to a new report by Reports and Data. The medication is widely used in the treatment of acute attacks of malaria, and rheumatoid arthritis, among other conditions. The fact that the medicine is a chemotherapeutic agent, which acts against erythrocytic forms of malarial parasites, is one of the major reasons for its extensive use in malaria treatment, which is in high demand in third world countries due to high incidence rate of malaria. However, with COVID-19 pandemic, the scenario in terms of demand for the medication has changed drastically, which sudden interest of nations like the U.S. on getting the medication. This sudden elevation in demand of the mediation is attributed to its demonstrated antiviral activity against (SARS–CoV-2), severe acute respiratory syndrome–coronavirus 2 in certain clinical studies.
However, one of the major adverse impact of the outbreak on the growth of the market and which may act as a hindrance in exploring the scope for expansion is the issue of supply chain being faced by a large number of market players. Major market players like IPCA, are also revealing about basic issues like lack of availability of food in long routes, which is also acting as a hindrance in long route deliveries. Concerns associated with the availability of the raw material for the medicine was also prevalent. However, China regaining its normalcy, from where most of the raw materials are sourced and backward integration of some industry players turned out to be effective in resolving the issue.
Companies considered and profiled in this market study:
Hikma Pharmaceuticals PLC, Cadila Healthcare Ltd, Ipca Laboratories Ltd, Novartis AG, Mylan N.V, Sanofi S.A., Taj Pharmaceuticals Ltd., Shanghai Pharmaceuticals Holding Co., Ltd, Torrent Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., and Zydus Cadila.
To get a free sample of this report, visit: https://www.reportsanddata.com/sample-enquiry-form/2933
Segments Covered in the report:
This report forecasts revenue growth at a global, regional country level, and provides an analysis of the industry trends in each of the sub-segments from 2017 to 2027. For the purpose of this report, Reports and Data have segmented the global Hydroxychloroquine market according to Product Type, Distribution channel, Application, and Region:
Product Type Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
Distribution channel Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
- Hospital pharmacy
- Online pharmacy
- Speciality drug stores
- Retail pharmacy
Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/2933
Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
- Rheumatoid arthritis
- Lupus Erythematosus
Regional Outlook (Revenue in USD Million; 2016–2026)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Hydroxychloroquine market.
Product Development/Innovation: Detailed insights on the upcoming technologies, RD activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Hydroxychloroquine market.
Read the Comprehensive Report with a meticulous TOC and panoramic coverage of the market: https://www.reportsanddata.com/report-detail/hydroxychloroquine-market
Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East Africa.